Ortikos Interactions
There are 566 drugs known to interact with Ortikos (budesonide), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 70 are major, 471 are moderate, and 25 are minor.
- View all 566 medications that may interact with Ortikos
- View Ortikos alcohol/food interactions (1)
- View Ortikos disease interactions (7)
Most frequently checked interactions
View interaction reports for Ortikos (budesonide) and the medicines listed below.
- acetaminophen
- acetaminophen
- Activated Charcoal (charcoal)
- Activated Charcoal (charcoal)
- Adderall XR (amphetamine / dextroamphetamine)
- Adderall XR (amphetamine / dextroamphetamine)
- albuterol
- albuterol
- Alinia (nitazoxanide)
- Alinia (nitazoxanide)
- Alka-Seltzer Gold (citric acid / potassium bicarbonate / sodium bicarbonate)
- Alka-Seltzer Gold (citric acid / potassium bicarbonate / sodium bicarbonate)
- Allegra (fexofenadine)
- Allegra (fexofenadine)
- amantadine
- amantadine
- Ambien (zolpidem)
- Ambien (zolpidem)
- amitriptyline
- amitriptyline
- amlexanox topical
- amlexanox topical
- amoxicillin
- amoxicillin
- amphotericin b
- amphotericin b
- aprepitant
- aprepitant
- Ativan (lorazepam)
- Ativan (lorazepam)
Ortikos alcohol/food interactions
There is 1 alcohol/food interaction with Ortikos (budesonide).
Ortikos disease interactions
There are 7 disease interactions with Ortikos (budesonide) which include:
- hepatic impairment
- infections
- lactose intolerance
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- hyperadrenocorticism
Report options
More about Ortikos (budesonide)
- Ortikos consumer information
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: glucocorticoids
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Rinvoq
Rinvoq (upadacitinib) is used to treat rheumatoid arthritis, psoriatic arthritis, atopic ...
Tremfya
Tremfya (guselkumab) injection is used to treat plaque psoriasis, psoriatic arthritis, ulcerative ...
Remicade
Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn's ...
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Infliximab
Infliximab infusion (brand names Avsola, Inflectra, Remicade, and others) reduces inflammation and ...
Adalimumab
Adalimumab is used to treat plaque psoriasis, Crohn's disease, ulcerative colitis, rheumatoid ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.